Factors influencing patient knowledge of warfarin therapy after mechanical heart valve replacement

Journal of Cardiovascular Nursing

Volumn 21, Issue 3, 2006, Pages 169-175

  Hu, Amanda ^a   Chow, Chi Ming ^a,b   Dao, Diem ^b   Errett, Lee ^a,b   Keith, Mary ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Anticoagulants; Heart valve prosthesis; Patient education; Socioeconomic factors; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; VITAMIN K GROUP; WARFARIN;

ARTICLE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; FEMALE; FOOD DRUG INTERACTION; HEALTH SURVEY; HEART VALVE REPLACEMENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATIENT EDUCATION; THROMBOEMBOLISM;

ANTICOAGULANTS; CROSS-SECTIONAL STUDIES; FEMALE; FOOD-DRUG INTERACTIONS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PATIENT EDUCATION; POPULATION SURVEILLANCE; THROMBOEMBOLISM; VITAMIN K; WARFARIN;

EID: 33745662668     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/00005082-200605000-00003     Document Type: Article

References (46)

1. Bristol-Myers Squibb. Coumadin Care: Patient Information Booklet. Montreal, Quebec: Bristol-Myers Squibb Canada Inc; 2002.
2. Warfarin. In: Welbanks L, ed. Compendium of Pharmaceuticals and Specialties, 35th ed. Ottawa: Canadian Pharmacists Association; 2000:382-385.
3. Wilson FL, Racine E, Tekieli V, Williams B. Literacy, readability and cultural barriers: critical factors to consider when educating older African Americans about anticoagulation therapy. J Clin Nurs. 2003;12(2):275-282.
4. Roddie AMS, Pollock A. Therapeutic control of anti-coagulation: how important is patient education? [letter]. Clin Lab Haematol. 1988;10:109-112.
5. Ellis RF, Stephens MA, Sharp GB. Evaluation of a pharmacy-managed warfarin monitoring service to coordinate inpatient and outpatient therapy. Am J Hosp Pharm. 1992;29:387094.
6. Hennessy BJ, Vyas M, Duncan B, Allard SA. Evaluation of an alternative model of anticoagulant care. Ir J Med Sci. 2000;169:34-36.
7. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Ann Intern Med. 2000;133:687-695.
8. Tang EO, Lai C, Lee K, Wong R, Cheng G, Chan T. Relationship between patients' warfarin knowledge and anticoagulation control. Ann Pharmacother. 2003;37:34-39.
9. Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol. 2002;54(6):657-664.
10. Dillman DA. Mail and Internet Surveys: The Tailored Design Method. New York: Wiley; 2000.
11. Brigden M, Smith RE. How to Use Coumadin Safely and Effectively. [video] Dupont Pharma.
12. Colwell N, O'Neill T, Tyrrell J, Roberson K, Clarke R, Graham I. An evaluation of an anticoagulant clinic. Ir Med J. 1990;83:94-97.
13. Taylor FC, Ramsay ME, Tan G, Gabby J, Cohen H. Evaluation of patients' knowledge about anticoagulant treatment. Qual Health Care. 1994;8:67-68.
14. McCormack PM, Stinson JC, Hemeryck L, Feely J. Audit of an anticoagulant clinic: doctor and patient knowledge. Ir Med J. 1997;90:192-193.
15. Heller R, Knapp J, O'Connell R, et al. Effectiveness of anticoagulation among patients discharged from hospital on warfarin. The Newcastle Anticoagulation Study Group. Med J Aust. 1998;169:243-246.
16. Cheah GM, Marten KH. Coumadin knowledge deficits: do recently hospitalized patients know how to safely manage the medication? Home Healthcare Nurse. 2003;21(2):94-100.
17. Katz SJ, Hofer TP, Manning TP. Hospitalization utilization in Ontario and the United States: the impact of socioeconomic status and health status. Can J Public Health. 1996;87(4):253-256.
18. Cairney J, Arnold R. Social class, health and aging: socioeconomic determinants of self-reported morbidity among the noninstitutionalized elderly in Canada. Can J Public Health. 1996;87(3):199-203.
19. Alter DA, Naylor CD, Austin P, Tu JV. Effects of socioeconomic status on access to invasive cardiac procedure and on mortality after acute myocardial infarction. N Engl J Med. 1999;341(18):1359-1367.
20. Kapral MK, Wang H, Mamdani M, Tu JV. Effect of socioeconomic status on treatment and mortality after stroke. Stroke. 2002;33(1):268-273.
21. Pilote L, Joseph L, Belisle P, Penrod J. Universal health insurance coverage does not eliminate inequities in access to cardiac procedures after acute myocardial infarction. Am Heart J. 2003;146(6):1030-1037.
22. Winkleby MA, Cubbin C. Influence of individual and neighbourhood socioeconomic status on mortality among black, Mexican-American, and white women and men in the United States. J Epidemiol Community Health. 2003;57(6):444-452.
23. Ben-Shlomo Y, Chaturvedi N. Assessing equity in access to health care provision in the UK: does where you live affect your chances of getting a coronary artery bypass graft? J Epidemiol Community Health. 1995;49(2):200-204.
24. Ancona C, Agabiti N, Forastiere F, et al. Coronary artery bypass graft surgery: socioeconomic inequalities in access and in 30 day mortality. A population-based study in Rome, Italy. J Epidemiol Community Health. 2000;54(12):930-935.
25. Michelozzi P, Perucci CA, Forastiere F, Fusco D, Ancona C, Dell'Orco V. Inequality in health: socioeconomic differentials in mortality in Rome, 1990-95. J Epidemiol Community Health. 1999;53(11):687-693.
26. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703-710.
27. Conlin KK, Schumann L. Literacy in the health care system: a study on open heart surgery patients. J Am Acad Nurse Pract. 2002;14(1):38-42.
28. Estrada CA, Hryniewicz MM, Higgs VB, Collins C, Byrd JC. Anticoagulant patient information material is written at high readability levels. Stroke. 2000;31(12):2966-2970.
29. Davis TC, Couch MA, Wills G, Miller S, Abdehou DM. The gap between patient readability of patient education materials. J Fam Pract. 1990;31(5):533-538.
30. Williams MV, Parker RM, Baker DW, et al. Inadequate functional health literacy among patients at two public hospitals. JAMA. 1995;274(21):1677-1682.
31. Weiss BD, Reed RL, Kligman EW. Literacy skills and communication methods of low-income older persons. Patient Educ Couns. 1995;25(2):109-119.
32. Shah M, Coyle Y, Kavanaugh A, Adams-Huet B, Lipsky PK. Development and initial evaluation of a culturally sensitive cholesterol-lowering diet program for Mexican and African American patients with systemic lupus erythematosus. Arthritis Care Res. 2000;13(4):205-212.
33. Kiger H. Outreach to multiethnic, multicultural, and multilingual women for breast cancer and cervical cancer education and screening: a model using professional and volunteer staffing. Fam Community Health. 2003;26(4):307-318.
34. Williams PB. HIV/AIDS case profile of African Americans: guidelines for ethnic-specific health promotion, education, and risk reduction activities for African Americans. J Clin Nurs. 2003;26(4):289-306.
35. Griffin JP, Griffin JP. Informing the patients. J R Coll Phys. 1996;30:107-111.
36. Lambert HN, Wynne HA. Effect of age and length of therapy upon attitudes to and knowledge about warfarin. J R Soc Med. 2003;96:572.
37. Roche-Nagle G, Chambers F, Nanra J, Bouchier-Hayes D, Young S. Evaluation of patient knowledge regarding oral antiocoagulants. Ir Med J. 2003;96:211-213.
38. McMahon T, Clark CM, Bailie GR. Who provides patients with drug information? BMJ. 1987;294:355-356.
39. Ansell J, Jacobson A, Levy J, Voller H, Hasenkam JM. Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self Monitoring Association for Anticoagulation. Int J Cardiol. 2005;99:37-45.
40. Menendez-Jandula B, Souto JC, Oliver A, et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Ann Intern Med. 2005;142:1-10.
41. Amrusa NA. Ability of clinical pharmacists in a community pharmacy setting to manage anticoagulation therapy. J Am Pharm Assoc. 2004;44:467-471.
42. Yanchick JK. Implementation of a drug therapy monitoring clinic in a primary care setting. Am J Health Syst Pharm. 2000;15(suppl 4):S30-S34.
43. Kornblit P, Senderoff J, Davis-Ericksen M, Zenk J. Anticoagulation therapy: patient management and evaluation of an outpatient clinic. Nurse Pract. 1990;15:21-26, 29, 32.
44. Khan TI, Kamali F, Kesteven P, Avery P, Wynne H. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. Br J Haematol. 2004;126:557-564.
45. Viller F, Guillemin F, Briancon S, Moum T, Surrmeijer T, van den Heuvel W. Compliance to drug treatment in patients with rheumatoid arthritis: a 3-year longitudinal study. J Rheumatol. 1999;26:2114-2122.
46. George CF, Waters WE, Nicholas JA. Prescription information leaflets: a pilot study in general practice. BMJ. 1983;287:1193-1196.